New mimic of relapse or regional lymph node metastasis in a cancer survivor: a case of mRNA COVID-19 vaccine-induced lymphadenitis with high FDG uptake.

IF 2.7 Q3 IMMUNOLOGY
Immunological Medicine Pub Date : 2022-03-01 Epub Date: 2021-12-16 DOI:10.1080/25785826.2021.1999786
Yusuke Tsumura, Koiku Asakura, Ikuko Takahashi, Mitsuko Akaihata, Yoshiyuki Takahashi, Yuji Ishida
{"title":"New mimic of relapse or regional lymph node metastasis in a cancer survivor: a case of mRNA COVID-19 vaccine-induced lymphadenitis with high FDG uptake.","authors":"Yusuke Tsumura,&nbsp;Koiku Asakura,&nbsp;Ikuko Takahashi,&nbsp;Mitsuko Akaihata,&nbsp;Yoshiyuki Takahashi,&nbsp;Yuji Ishida","doi":"10.1080/25785826.2021.1999786","DOIUrl":null,"url":null,"abstract":"<p><p>Western countries that were first to administer the COVID-19 vaccination report cases of vaccine-induced axillary lymphadenitis with high FDG uptake. However, no such findings have been reported from any Asian countries. We report here a confusing case of a 31-year-old female cancer survivor with high FDG uptake in her axillary lymph nodes, suggesting recurrence, following mRNA COVID-19 vaccination. Although the value of SUV<sub>max</sub> was elevated (12.7), additional imaging revealed that her lymphatic lesions were benign, and they resolved spontaneously. This case of a strong immune reaction to COVID-19 vaccination in regional lymph nodes is the first reported in a Japanese patient. We should be aware of this new mimic and optimize diagnostic imaging methods accordingly in the era of COVID-19.</p>","PeriodicalId":37286,"journal":{"name":"Immunological Medicine","volume":"45 1","pages":"45-47"},"PeriodicalIF":2.7000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/25785826.2021.1999786","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Western countries that were first to administer the COVID-19 vaccination report cases of vaccine-induced axillary lymphadenitis with high FDG uptake. However, no such findings have been reported from any Asian countries. We report here a confusing case of a 31-year-old female cancer survivor with high FDG uptake in her axillary lymph nodes, suggesting recurrence, following mRNA COVID-19 vaccination. Although the value of SUVmax was elevated (12.7), additional imaging revealed that her lymphatic lesions were benign, and they resolved spontaneously. This case of a strong immune reaction to COVID-19 vaccination in regional lymph nodes is the first reported in a Japanese patient. We should be aware of this new mimic and optimize diagnostic imaging methods accordingly in the era of COVID-19.

癌症幸存者复发或局部淋巴结转移的新模拟物:mRNA - COVID-19疫苗诱导的淋巴结炎伴高FDG摄取病例
最早接种COVID-19疫苗的西方国家报告了疫苗诱导的腋窝淋巴结炎病例,并伴有高FDG摄取。然而,在任何亚洲国家都没有这样的发现。我们在此报告一例令人困惑的病例,一名31岁女性癌症幸存者腋下淋巴结FDG摄取高,提示在mRNA COVID-19疫苗接种后复发。虽然SUVmax值升高(12.7),但进一步的影像学显示她的淋巴病变是良性的,并且自发消退。这是在日本患者中首次报道的区域性淋巴结对COVID-19疫苗接种产生强烈免疫反应的病例。我们应该意识到这种新的模拟,并在新冠肺炎时代相应地优化诊断成像方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Immunological Medicine
Immunological Medicine Medicine-Immunology and Allergy
CiteScore
7.10
自引率
2.30%
发文量
19
审稿时长
19 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信